Leadership changes at MusclePharm

Brad Pyatt resigns as President effective April 16 but will continue to serve as CEO and  COB. Richard Estalella appointed as President.

CFO L. Gary Davis resigns effective April 15 but will work on special projects until December 31, 2014.

Board member Donald Prosser resigns effective April 16 to assume the CFO role.

(MSLP) regulatory filing.

From other sites
Comments (2)
  • for2n8johnny
    , contributor
    Comments (126) | Send Message
    What comes next...announcement of SEC investigation??
    14 Apr 2014, 10:12 AM Reply Like
  • dindin21
    , contributor
    Comments (169) | Send Message
    Why do you say that? This is good news.
    14 Apr 2014, 12:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs